These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21200314)

  • 1. Targeted therapies and thyroid cancer: an update.
    de la Fouchardiere C; Droz JP
    Anticancer Drugs; 2011 Aug; 22(7):688-99. PubMed ID: 21200314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targeted therapies for patients with refractory thyroid cancer.
    Chougnet C; Brassard M; Leboulleux S; Baudin E; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):448-55. PubMed ID: 20554167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular targeted therapies in thyroid cancer.
    Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
    Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging molecular therapies of advanced thyroid cancer.
    Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G
    Mol Aspects Med; 2010 Apr; 31(2):215-26. PubMed ID: 20176050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on thyroid cancer treatment.
    Regalbuto C; Frasca F; Pellegriti G; Malandrino P; Marturano I; Di Carlo I; Pezzino V
    Future Oncol; 2012 Oct; 8(10):1331-48. PubMed ID: 23130931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
    Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
    Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of thyroid cancer.
    Sherman SI
    Biochem Pharmacol; 2010 Sep; 80(5):592-601. PubMed ID: 20471374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy for thyroid cancer: An updated review of investigational agents.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic advances in the management of progressive thyroid cancer.
    Woyach JA; Shah MH
    Endocr Relat Cancer; 2009 Sep; 16(3):715-31. PubMed ID: 19218279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary thyroid cancer: therapeutic targets and molecular markers.
    Ball DW
    Curr Opin Oncol; 2007 Jan; 19(1):18-23. PubMed ID: 17133107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in advanced differentiated thyroid cancer.
    Carneiro RM; Carneiro BA; Agulnik M; Kopp PA; Giles FJ
    Cancer Treat Rev; 2015 Sep; 41(8):690-8. PubMed ID: 26105190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel treatment of medullary thyroid cancer.
    Sugawara M; Geffner DL; Martinez D; Hershman JM
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):367-72. PubMed ID: 19633548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies for thyroid carcinoma.
    Walsh S; Prichard R; Hill AD
    Surgeon; 2012 Feb; 10(1):53-8. PubMed ID: 22233555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
    Vaccaro A; Chen H; Kunnimalaiyaan M
    Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies for advanced thyroid cancer.
    Puxeddu E; Romagnoli S; Dottorini ME
    Curr Opin Oncol; 2011 Jan; 23(1):13-21. PubMed ID: 21045687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent thyroid cancers--is there a light in the horizon?
    Rovere RK; Awada A
    Curr Opin Oncol; 2008 May; 20(3):245-8. PubMed ID: 18391621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies].
    Malouf G; Baudin E; Soria JC; Schlumberger M
    Bull Cancer; 2009 Jan; 96(1):95-101. PubMed ID: 19211364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers.
    Sherman SI
    J Clin Endocrinol Metab; 2009 May; 94(5):1493-9. PubMed ID: 19258410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.